These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6397623)

  • 1. [New mineralocorticoids and mineralocorticoid-like steroids].
    Sekihara H
    Nihon Rinsho; 1984 Nov; 42(11):2552-6. PubMed ID: 6397623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiological and physiopathological significance of steroid hormones in hypertension].
    Tomizuka T; Tamura Y
    Nihon Rinsho; 1992 Apr; 50 Suppl():370-3. PubMed ID: 1635217
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineralocorticoids in normal and hypertensive pregnancies.
    Ehrlich EN
    Semin Perinatol; 1978 Jan; 2(1):61-71. PubMed ID: 216116
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedione.
    Griffing GT; Holbrook M; Melby JC; Brodie AH
    Clin Physiol Biochem; 1988; 6(3-4):171-8. PubMed ID: 3203487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical factors in hypertension.
    Griffing GT; Melby JC
    J Clin Pharmacol; 1985; 25(5):318-27. PubMed ID: 3897295
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of steroids in human essential hypertension.
    Gomez-Sanchez CE
    Biochem Pharmacol; 1982 Mar; 31(6):893-7. PubMed ID: 6282283
    [No Abstract]   [Full Text] [Related]  

  • 7. An approach to mineralocorticoid hormone hypertension.
    Biglieri EG
    Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.
    Sharma KK; Lindqvist A; Zhou XJ; Auchus RJ; Penning TM; Andersson S
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):79-86. PubMed ID: 16337083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
    Baxter JD; Schambelan M; Matulich DT; Spindler BJ; Taylor AA; Bartter FC
    J Clin Invest; 1976 Sep; 58(3):579-89. PubMed ID: 182723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 4-hydroxyandrostenedione on 19-hydroxylation of deoxycorticosterone in the golden Syrian hamster.
    Dale SL; Holbrook MM; Brodie AM; Melby JC
    Steroids; 1988; 51(1-2):185-93. PubMed ID: 3242166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid hormones.
    Stockigt JR
    Adv Steroid Biochem Pharmacol; 1976; 5():161-238, 334-5. PubMed ID: 180781
    [No Abstract]   [Full Text] [Related]  

  • 12. Mineralocorticoid like effect of new 18-hydroxy-steroid isolated from urine of hypertensive patients.
    Palem-Vliers M; Fontaine F; Genard P
    Endocrinol Exp; 1976 Mar; 10(1):59-63. PubMed ID: 1083802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium and mineralocorticoids in normal and abnormal pregnancy.
    Lindheimer MD; Katz AI; Nolten WE; Oparil S; Ehrlich EN
    Adv Nephrol Necker Hosp; 1977; 7():33-59. PubMed ID: 208408
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of mineralocorticoid secretion by the superfused fetal monkey adrenal gland: lack of stimulation of aldosterone by ACTH.
    Seron-Ferre M; Biglieri EG; Jaffe RB
    J Dev Physiol; 1990 Jan; 13(1):33-6. PubMed ID: 2167907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid hypertension due to hyperaldosteronism and hyperdeoxycorticosteronism.
    Biglieri EG; Kater CE; Arteaga EA
    J Hypertens Suppl; 1986 Dec; 4(5):S61-5. PubMed ID: 3553487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid resistance.
    Geller DS
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin].
    Roger M; Nahoul K; Laloy E; Scholler R
    Ann Med Interne (Paris); 1983; 134(3):238-41. PubMed ID: 6625419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertensinogenic steroids].
    Kudo K; Abe K; Yoshinaga K
    Nihon Rinsho; 1984 Nov; 42(11):2547-51. PubMed ID: 6397622
    [No Abstract]   [Full Text] [Related]  

  • 19. Mineralocorticoids in normal pregnancy.
    Ehrlich EN; Nolten WE; Oparil S; Lindheimer MD
    Perspect Nephrol Hypertens; 1976; 5():189-201. PubMed ID: 63938
    [No Abstract]   [Full Text] [Related]  

  • 20. 19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
    Sekihara H
    J Steroid Biochem; 1983 Jul; 19(1A):353-8. PubMed ID: 6310235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.